Home India Ministry of Health and Family Welfare Postponement of the Seventh Expert Committee Meeting from 29...
Date: 2014-08-22 Category: Not Applicable State: Union Government Country: India

Postponement of the Seventh Expert Committee Meeting from 29.08.2014 to 05.09.2014 to examine the matters related to the approval of the safety and efficacy of Fixed Dose Combinations(FDC's) permitted for manufacture for sale in the country without due approval from office of DCG(I)

Issued by Ministry of Health and Family Welfare · Central Drugs Standard Control Organization

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

Here's a summary of the policy text, following your specified structure: **Executive Summary:** This document refers to a meeting scheduled for September 5, 2014, at FDA Bhawan, New Delhi, regarding specific drug formulations. The meeting addresses issues related to applications for product permission. Firms are requested to confirm their participation via email. **Key Points / Main Content:** * **Meeting Details:** * Date: September 5, 2014 * Time: 6:00 PM * Location: Conference Room, 1st floor, FDA Bhawan, Kotla Road, New Delhi * Purpose: Discussion regarding product permission applications. * **List of Firms/Institutes and Products under Consideration:** * Vivimed labs: aluminium hydroxide * Restech Pharma: Dried aluminium hydroxide * Acron Pharmaceutical: Aluminium Hydroxide * Skan research lab: Dried alumniniun ,hydroxide gel * Seivok Pharmaceuticals: Aluminium Hydroxide Gel * Livin Formulations : Aluminium hydroxide Paste * Eshpar Industries: Dried Aluminium * Abaris Healthcare: Omezole liquid * Indooo Remedies: Dimethicone * unibiotech formulations: Simethicone suspension * S.Indooo Remedies: Simethicone Drops * Dagon Pharmaceuticlas: Simethicone Drops * Next Wave: Simethicone * Pharma Synth Formulations : Aluminium hydroxide * Espi Industries: Dimethicone * Galpha Laboratories: Aluminium hydroxide * Wallace Pharmaceuticals: Dried Aluminum Hydroxide * Shivalik Remedies: Aluminium hydroxide Paste * Rexer pharma: Aluminium hydroxide Paste * Livin Formulations: Aluminium hydroxide Paste * Hema Laboratories: Dried Aluminium * Hippo Labs: Alpha Amylase IP * Unibiotech Formulations: Alpha Amylase IP * Shreya Life Sciences: Alpha Amylase IP * Cactel Laboratories: Pungal Diagtase IP * S.Noel Pharma: Fungal Diastase P * Laborate Pharmaceuticals: Fungal Diastase IP * Elan Pharma: Diastase IP * Darwins Formulations: Fungal Diastase 1:1 * Shreya Life Sciences: Amylase pepsin fungal Diastase * pernax lab itd: alphaamylase * Sunrise International Labs: Diastase * Elder Pharmaceutical Lid: Diastase * Noel: Diastase * GKM Nrere: Pungal Diastase * Versatile Pharma: Fungal Diastase * P B Phameaceuticals: Fungal Diastase * Cartel laboestories: fungal diastase * R. BHC Lab: Fungal Diastase IP * Dr. Sain's Laboratories: Pungal Diastase * Hippo Labs: Pungal Diatase * **Action Item:** * Firms are requested to confirm their participation by email at fdedivision@gmail.com **Impact Analysis:** **Pharmaceutical Firms/Institutes Listed:** * Impact: Their product permission applications are under discussion. Attendance is expected at the meeting to address potential queries related to their applications. * Action Required: Confirm participation by email (fdedivision@gmail.com), prepare to present relevant information about their product applications, and attend the meeting on September 5, 2014. **FDA Directorate:** * Impact: Responsible for organizing and conducting the meeting to review the product permission applications. * Action Required: Ensure all necessary preparations for the meeting are completed, communicate effectively with the participating firms, and document the outcomes of the meeting.

Key Entities Referenced

FDA Bhawan, Kotla Road, New Delhi: Location of the meeting. Vivimed labs: Name of a firm/institute listed in the document. Restech Pharma: Name of a firm/institute listed in the document. Acron Pharmaceutical: Name of a firm/institute listed in the document. Skan research lab: Name of a firm/institute listed in the document. Seivok Pharmaceuticals: Name of a firm/institute listed in the document. Himachal Pradesh: State where Baddi is located, relevant to Dagon Pharmaceuticals. Chandigarh: Union Territory where Unibiotech Formulations is located.
Official Source Record View Original Source →
See Full Document Text
FDA Bhawan, Kotla Road, New Delhi Te N22 AUG 2014 C4 -2. GDS DD errur n.,. p e e KfGS r.r ou a sd lS Np wh a Cei a r ocr m a ui i yaG nl , cau i inp Pt l,t ry a o MPH f, oro , sosP pf&pr i.i Ho t t &f e aiae lal s ,d H,s C e,To haur eD d k& e n. ,d p n o t aH Dj t iee .i p .a O tSd .fq, u oHD a fee r p p Het a e,, t p N o ao a l tf g o o G p lga oyus g,r +t y G, Gr ,. o uM Be Mwa .n ahh t Pa dae ar t rr na i ao s tl sMh o Hetg Modry esia, p dc . i iG a t co al av l lC ,e o Cr Nl on l e lem w lge ee n D, ge t eG l auM he nw id h di a Rc t aa i jl i C vo Gl ale ng de h & i Subject:- tsN1 haa1 f eP t: e o i c0 ts o o0 yt n u a aap n. l no tm n d r, Be y a em t l f we o f in iB t6 ct h h: a oa0 co uw0 yf t a o t dnp fh u,. e F em iN. s ax e e peiv pw dne r n Dt oDt h o veh e s at eh lCE i ox fC-p n ro1e f m o1r e 0 b mt r 0 i o e 0 n fC 2n a fo ,c it m e citm e o oR oi no et fso xt ( Dame CFm,e GDi (M CI n 1"e e s ) e ) -f tt l rh pi o ee eon g rrg am, m r a if F dt tr itD t no e eA gm r d .s 2 B f r9 oh e. ra l 0 mw a8 ata. e nn2 d u0 , 1 f t4 K ao o ct at to pl u pa r0 r 5 eR o. o fv0 oa a9 r. ld 2 , so0 a f1 N l4 ee t a iha nr et Sir, Reference is invited to this Directorate's Office letter u2d n9a dt . ee 0 rd 8 ,: . 201 12 4. .0 8 N. o2 w01 ,4 t hr ee q su ae is dt mi eng e ty io ngu ht ao s P ba er et ni c Pi opa st te p oi nn e da f to or e 0s 5a .i 0d 9 .M 21 e0 0, 1e 4t4 .i- n0 Tg1 h / ew2 h d0 ei1 tc3 ah- i lD w eC da ( s aM g i s es c ne h d. e a d 1 fu3 ol r- e P d tS heC t o m - eP b et e t- iM h ne e ge lt d ii s n o ag n s) S.No. | Name of firm/ Institute 1 1. Vivimed labs oi x. eM ta ag can ie ns ei u 1m 0 mhy gd r oo rx ali d le i q9 u8 id mgD r +u ag lminium hydroxide 0 251 g 2.Restech Pharma 2 v. adroxide Dried at 1u 0m 0i mn gi u +m oxh ey td ar co ax ii nd ee 10g mef g L3 i0 q0 ui d m sg us pe+ n sim oa ngnesium 3.Acron Pharmaceutical +3_ MO ax ge nt ea sca ii un me Hyd1 r0 oxm ig d e 2+ 8A ml gu Om ri an li Su um s penH sy id or noxide 0,298mg 4.Dried alumniniun’ ,hydroxide gel 130 mg + magnesium 4.Skan research lab hydroxide 150 mg + oxetacaine 5 mg suspension *-Seivok Pharmaceuti=c als A5.lOuxmeitnaicuaimn e HBydPr ox1i0dmeg +GeAll umIiPn i0um2 9H1ygdmr oxeiqd,e tego. 0t.o 3d8r0igemd +Magnesiurn Hydroxide IP 98mg Suspension 2 TifbeLa 2j 5s 0al mu gm i +n Si iu mm e th‘ ih cy od nr eox Sid Oe m gg e +l O xe2 t3 a0 cm aig n e7 fM 0a mg gn e Os ri ala m su st py ed nsr io oa nde 2.Livin Formulations : SP2 ua. ssA ptl eeu n+m sSi iin omi neu tm h icoh ny ed +r Oo xx ei td ae c ai— n p ea ste 1+ . 57 gM ma +g 1n .e 2s 5i gu mm + 50h my gd +r 1ox 0i md ge- CA1 hl. eA u wl mg aii bnn li i ec u m TA ac bHi ly ed d t r so2 x0 i0 dm eg 3+ 0S 0o gdi u +m Bicar jb uo mn at He y d7 ro0 xm ig d e+ SDr ei ne gd 4 12 ..E Ps hp ai r mIn ad Su yst nr ti he s Formulstions OCA |2 ih .l. ?AeA u cl w 0m tg .ai ii 0b vnn 0l ai i 0tec u e 7 m d mTA a !Dc b H i Oli y m red d e at r t lso2 h Lix0 ici0 qod um ne ig e d 1 I5+ P 0S 4o m 0d g mi gu + m M + Da igB li n lc e Oa sr iib uo Bmn P a t H 0e y . d 07 r 0o0 5x mm i lg d +e F + eD 7 nr 5 ni m ee lgd 2.Abaris Healthcare E2 rD uit l! s loO ni g 3B P o 4o 0s mm gi O+ rF e Lin qn ue it d oii 0.0007! +Simethicone 3.Indooo Remedies 03 .. 0D 0im 0e 7t mh !i Sc yo rn ue p IP 40mg +Dill oil BP 0.005mi *+Fennel oil USP 4.unibiotech formulations 04 .. 0S 0i 5m e mt ih i dc ro on pe S e um su pl es ni so ion n 40 mg + fennel oi! Dill oit 0.007 mi + S.Indooo Remedies *5 D. iS li m Oe it lh Bic Po n 0e . 0E 0m Su ml ls +i Fo en n nU eS lP o i!e q U. S t Po 0S .i 0m 0e 0t 7h mi !c o On re a lU DS rP op s40mg 6.Dagon Pharmaceuticlas 96 .. 0S 0i 0m 7et mh li c Co on le i ge om du rls oi po sn 40mg +Dill oi! 0.005m) +Fennel oil 7.Next Wave O7 r. aS li m Le it qh ui ic done mg +Dill Oil 0.00mi *Fennel oi 0.0007m) $ 1.Pharma Synth Formulations 2.Espi Industries 3.Galpha Laboratories 4. Wallace *H3 Sy oA d rl r bu o im x tii oldn ei S ou P lm a u s tt ie aH ny [ d 7pr 5o 2 0x 0 mi 0 gd m e Sg y r+P uAa pcs tt ie v atJ ep d Di3 m0 e0 tm hg ic on+ eM a [Pg p n 1e 2s 5iu mm g Pharmaceuticals o+4 ra. acA ltl iu vm ai ten di u Cm i mH ey td ir jo ox éoi nd ee 4 3 00 m0 gm +g s o+ rM ba itg on le ss oi lu utm i oh ny d 1r 0ox 0i 0d me g 2 l5 i0 qum ig d 6 1Shivalik Remedies 2.Rexer pharma 3.Livin Formulations g3 e. tA l 1u .mi 5n 7ium hydroxide Paste eg. to Dried Aluminum Hydroxide = Magnesig um m Heg y. d rt oo x 2 id5 e0 Im Pg 1 + .M 14a gg mn e egs .i u tom 2h 5y 0d mro gx +i Sd ie m P ea ts ht ie c oe nq e. It Po 2 * . ee ee - — wee . I Re50mg Oral Suspension 54 ,. CR arP tG el L li af be os rc ai te on rc ie es s H4. yD dr ri oe xd i deA l Bu Pm 1i 5n 0i mu gm +SH iy md er to hx ii cd oe n e BB PP 403 m0 g0 Um ng c oa+ tM eda g Tn ae bs lei tu sm aS l. uSi mm ie nt ih ui mc o hn ye d r$ o0 xi dm eg g e+ l 2m 5a 0g n Me gs i su um sp eh ny sd ir oo nxide pel 250 mg + 6.Hema Laboratories 6 2. 5S 0i .m 0e mt gh ic to yn ge eg5 n0 e. s0 im ug m + HD yr di re od x idA el um 2i 5n 0i .u 0m m g Hy Md or no ox rid ie n -MG Pe Sl l,Hippo Labs 1 Alpha (12000) 10mg +Papain 20mg Syrup 2.Unibiotech Formulations 2.Alpha Amylase IP 100mg +Papain IP 50mg Syrup 3.Shreya Life Sciences 3.Alpha Amylase IP 125mg +Papain IP 40mg Syrup 4.Cactel Laboratories 4Pungal Diagtase IP Sémg +Pupain IP 10mg Syrup S.Noel Pharma 5.Fungal Diastase [P 12.5mg +Papain IP 7.Sing Syrup 6.Laborate Pharmaceuticals 6.Fungal Diastase IP S0mg +Papain IP 60mg Syrup 7.Elan Pharma 7-Diastase IP 100mg +Papain IP Gmg Tablets 8 1. .S Da ai rn w iM ne d Foi rc ma um le an tt is o ns |8. -Fu An iga pl hs AD mi ya lst aa ss ee (1:(1 2: 01 020 00 ) ) SIP O mS gO m +p P e+ ps in IPn 1i 0P m6 g0m Sg y r§ up 2.Shreya Life Sciences 62 2. .A 5-A mm gy +l Pa es pe s i( nF u In Pg 2al 0 D mi ga s St oa ls ue t i1 o: n8 f0 o0 r f Or ro am l aA ds mp ie nr ig si tll ru as t io or nyzae) IP 3.pernax lab itd 3.alpha-amylase 62.5 mg * pepsin 20 mg oral Syrup 4.Sunrise International Labs d4 Oi. g mD ei s ga ts s St a yns roe t u pI JeP s s( F tu hn ang a 6l 0 D gi ma ss t oa fs e c oG oe cr ki ev de d s tf rr ao chm ) a Ss Ope mr gg i +ll u Ps e po sr iy nz Ia Pe 5-Diastase IP SOmg + Pepsin 10mg Oral Liquid S.Elder Pharmaceutical Lid 6.Noel 6.Diastase 33.33mg +Pepsin Smg Drops a 7.Dinstase 50mg +Pé e' psin 10mg Syrup 7,GKM Nrere 8.Pungal Diastase (1:1200) IP 50mg +Pepsin (1:3000) IP 10mg 8. Versatile Pharma Syrup 9.P & B Phameaceuticals 9.Fungal Diastase (1:2500) 62.5mg +Pepsin IP 20mg Oral Liquid 10,Cartel laboestories 10.fungal diastase $0 mg + pepsin 10 mg syrup L1 R. BHC Lab 11 .Fungal Diastase IP (1:1200) 1P $0mg +Pepsin IP (1:2000) Omg eneus Hard Geletin 12.Pungal Diastase [P (1:1200) It IP 50mg +Pepsin IP (1:3000) . 3 oe- - 12.Dr. Sain's Laboratories | 10mg Syrup ” 13.Hippo Labs '3.Pungal Diatase (1:1200) Smg +Pepsin(1:3000) 10mg Syrup veut are requested kindly to make it convenient to attend the said meting on 05.09.2014 to 6:00) p.m. in the Conference Room, Ist floor, FDA Bhawan, Kotla Road, Near National Bal Ba ht a 1 w1 a: n0 ,0 a N. em w. s T M LAA i ae/ r um lD ro i iA nr e ea s &f n o od r n Cu l os m y .t t a wNe no hn d,d o i 4 tn i- h sg 0 e t 1t ha/h eie 2 r a 0 utm 1 i te 3 c he k- oet D rti C isn , z(g eM i dfia ps Gs uc o r1 vw tc3e .- hl l P a a S s gs C e es ) d n tth h fo r on rog u t g hs 3 ih s. t a0 pgu 2 ue2 r n0 ptw 1 oi ,4 sl . sl e h ,oIb f ue lt r dp a a bvi e ed l l pea uds r cbp hye a r A s l ert d,h i i ts t h s rD hi oor ue u gc l ht do M r ba /et s e b ’ Bys a I lO nf mdf aii eac n re You are requested to confirm your participation by e-mail at fdedivision@gmail.com, Copy to: "at 2I .f 6MM 0// 5ss . 0, 0V 9Ri ev Psi ot nm e de c id h c hL ea P rb h rs a yr .L mi ad. ,, D B- -9 1, 8 4In /d 1u 8s 3t ,ri al P IA Pre Da I, C H a Ir ni dd uw sa tr ri, a lU tt Ea sr ta ak teh ,a nd M, ettupclayam, Pondicherry, P.C. L6543 .3 o .,. // (MMMPM EM ///o/ ai sssn sss . t..d,. )i FS W , cA aeS h D Mc llek uCr lvrao mr ao n Ln y ck b i. e aP mP R h P ih iPea . ta h sr C e -r ae m , dm 4raa ,a m6 0rc c a0 0c 1e e c5 4u h u 0e1 2t t 9u-0i iL 3t4c 7 c ,ia 8a . a c,l b l a s P s S l, o , .P sn 3 Vv d 18 Lt .i 4/ , t c 72 dh , R, . eL o G M r a Bi .a r d -d Lyi 3,D. .n 0 . J P 7 C oo@ /R g.n 3 o e,d 1a s W i A 2td V c n h ,, 7 th w - a FG aeb l l. rr, oi1 i r ra. y ( aT ,D lW h. B i )C Di. r ,l e, u i M chE m uu ks ov m t ru b Pa sn lt a a ae - i i z, 3 - a, 9 4N , a 6 0M Oz 0a f3o 1 fn 2d .0a 1n 2, ,a C . eA d D nih i tsm p t re e . a d t lN a a MCb v Isa o ad m Dr- m i C3 ,u 8 Rn G2 oue3 j a,3 a d r0 ,a, V t Ai G . nlu l dj i ha a er n ra urt i,, 8y 5M 0i 0s 0. 0 7E ,spi Industries & Chemicals Pvt. Lid, Plot No, M-7/2, Kakatiya Nagar, Habsiguda, Hyderabad- ¥ M A/ -1s 0, / 15, Shilenil IndustrialP h Ara er am ,a s Dy en tt hih - 110095, #* —— Formutations Limited, 10y AM/ hs. m A eBA dR aIS b aHE dALTHCARE PRIVATE LIMITED, 406, Saffron, Panchvatl, Ambsvadi, - 380 006, 1k. M 1/ 6s 0. 0 30U .nibiotech Formulations, Mr. J-K. Gulati, SCO-272, 1st Floor, Sector-32- D, Chandigarh - 12 SM/ ws a. rDa gg ho an t Pharmaceuticals Pvt Ltd, Opp Gurudwara, Baddi - Nalagarh Road, Manpara P.O, Pinjore- Rd, Baddi, Himachal Pradesh 174102. 13, M/s. Indoco Remedies Limited, Indoco House, 166, CST Road, Santacruz (Fast), I" 11 4, G MM ui irs sg, .a N Goe anx l t p« h(W Ha a Lv r ae by oa( rnI aan t}d o-i ra i1) e, 2 s C 2 0 LO 0 iR 2 g, GP O BR abA uT SE ak O pF aF lI C ME ar, g ,C W9 o8 r0 l ,S us Mh ua mn bt a L io ,k M, a P hh aa rse e tI irecM ou gm ob ia ei 400 098, 16y 0M/ 3s 9. NOEL Pharma, 24-85/7, Laxminaraysna Nagar Colony, New 1.D.A,, Uppal, Hyderabad - 17 ~, Mis, Pro Laboratories Pvt, Pvt. Led, 140-14), Mskkanpur, Bhagwanpur, Roorkee Dist, Han 4Uttrakhand, Haridwar — 249401. 221F 109 ,.,a M MD Mt ii ie ss she . ..r Rs a CR ad Pe r u x tGn e ev r lLRa Lio Pi f aa h e bd a s o,R r c r e m iB mem a oh ne ra cd P ig evi ew st se a L ,s Ln t t 2a ddP 4p ,,v -u Pt 12h. r 15 a. 2L ,s / i eP M 4-d . ,I I, C 1 . LD, K n2 I Ch 4 d C a 7 a Ls 6 , a or 6 nCa 7 dh. l,eN r R to io oh. aa ap rS na nk0 l ele9 yBy/ s e,1 , l- , C a2 h p e ur& rl a5 Rp2 oa0 al, l d y ,V , i N1l a1l 4 va / ig 2e / M B uB , mh T ba e ag l iw a -a n 4n g 0p a 0u n 7r a 0 5 SM 0 ,u 0 s 0, 5 1R .o 7’‘ ‘ Near Gvi Bio, IDA, Uppal, Hyderabad 22, DM ei hs r, adunH -e 2m 48a 1 9— 7, L Ua tb to ar ra at ko hr ai ne ds , Pvt. Lid. Selaqui Industrial Area Ph- a 5 r0 m0 a039 1 23, SM O/s D. D HH 1i .ppo Labs PVT LTD., Go utham Nagar, 8 273 Old Air Port Road, Hyderabad, Hyderal s > 24,. AM n/ ds h. e S rh ir Be ay sa t ,L Mi ufe m bS ac iie ,n Mc ae hs u P rr ai sv ha ét re a L sim oi eShreya House M/A, Parera Gill Road, Andheri 22 65 ;, MMM a// hss a.. r L aEa slb hao tnr r a aPt h 4e a 0P r 0h m 0a ar 8 m 8Ia nc de iu at i Pc va tl . i Ln id di .a L Si Om fi ,t e Rd a, i kE a-1 r1 , C hI and m. b eAr re ,a , G oP va an ni dp ie ,t- 1 D3 e2 o1 n0 u3 r, EB. Gowandi, Mu 22 38 ,, AM2 n/9 s. d.M h / rDs aa. r PS w ra i ai n dn e FM soe hr d 3mi 2uc 0la 0am 0te i 8n o .nt ss P P vv tt . L L ii dd ,, , $ 41 -0, 1 8A -V 37E /S 4, Bui Al Id Ri n Cg o, l S ou nl yt ,a n B B ea nz za r Ci, r H cly ed ,e Bra eb na zd C- i$ r0 c0 l0 e,9 5 V, ijayawada, 30 SM t/ as t. i oP na , r Sn ia ox n ,L Sa ib o nP ,r Miv ua mt be s L ii ,m i Mt ae hd a, r a1 s04 h- t1 r0 a7 4, 0 B 0u 0i 2l 2d .ing, No-8, Jogani Industrial Estate, Chunabhatti 33 2l ,y DMM e/i sss a,, l S E Ru l on dr aei drs , Pe Ah I nan drt m he a er cn ra e it u i (to Win c )a a ,l l L Msa u Pb mys bt, a. P il L -o t 4t d 0 ,N 0 o 0E 5l 1 d 30 e .0 r, HP oh ua sse e- ,I l P lI oD tA n, o .C h Ce -r 9l ,ap Da al lly i, a H Iy ndd ue sr ta rib ae ld E $ st0 a0 t0 e5 ,] O A fP f. Veera 33., Mis. GKM New Spl. Type Plot No. $ to 8, PIPDIC Electronic Park, Thirubavanai, 33 54 ., M M MHi i uys s md. . be r aPa i b & -V a 4e d 0r B s 0~ a P 0t $ hi 50l a 30 r ,0 m0 a7 cP , eh ua tr im ca ac le su t Li ic ma il ts e d, P 0v 9, , AL st “ hd i, ° rwnd8 .5 1- t6 2, L okhS at nr de wet a la N Co o. m ple8 x, , AnH da hb ea rs ii (g Wu )d ,s 33 76 ,. MM l/ ss .. B DrH SC a iL na sb L P abr oi rv aa tt oe r L ii ed s. , F 1a 0c 5to 4r Ny: §U n Ri ot a 1 d, H 9 a1 r/ i2 h, a D r. pL uC r. ,S, o B ua td hd Ti, w eDi ns tt yt. FS oo ul ra n P a( rH g. aP n,) as, West Bengal. Note for Firms: N ao ac ee m v te ed . ie am sn wulti pld ee b aa pt pe l iy co au ntr s ,t ec yh on ui c aa rl e t re ea qm u ef sr te p dr e ts oe n bt ea t pi ro en s. e nA ts ua fp pl Ci Dca st tio nn ofo nr s 05a .m 0e 9 .F 2D 6C 1 4b aa tv e 1 b 1e -0e 0s $ mmB eh o ea tw n iat ngno g, 6 dd 2 aaN0 tne0 e w p D 1. em ?l. h S ii i n - b1t i1h 0e t 0 hC 0 eo 2 n c f ote o pr ye m n a oc k fe e t hpR ero e pso rem en s, t ea nt1 ti" a o tnf i l oo s no s r o, c f o F n tsD hi eA d e r r eB e sh pd ea cnw tea icn ve, es s pK a rro y ot l b pa y e ltR sho e a tcd oo, t m eN m e ia tr t n eN esa yt io on fa tl h eBal cApp or n mer ys me ie n tots tta ehte e ei r ,on n mt an a uf” a cS ti urM ee r P wr ho og hS aam vp el e as p pi ln i eo dr ag bi ona vl e ’p a Fc Pk G ’a ss w me al yl as l sp oa c pk ra eg see n i t. n s te hr et i rw h ci al se e c bo efm oi rn eg tf ho er Yours faithfully, = Drugs C (Dr. G. eN n. e S ri an lg (h 1) ) ad

Continue your research